Improving genetic risk modeling of dementia from real-world data in underrepresented populations

被引:0
|
作者
Fu, Mingzhou [1 ,2 ]
Valiente-Banuet, Leopoldo [1 ]
Wadhwa, Satpal S. [1 ]
Pasaniuc, Bogdan [3 ]
Vossel, Keith [1 ]
Chang, Timothy S. [1 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Dept Bioinformat, Med Informat Home Area, Los Angeles, CA 90024 USA
[3] David Geffen Sch Med UCLA, Dept Computat Med, Los Angeles, CA 90095 USA
基金
美国国家卫生研究院;
关键词
ALZHEIMERS-DISEASE; DIAGNOSIS; VARIANTS; SCORE; IDENTIFICATION; METAANALYSIS; ASSOCIATION; ANCESTRY; PROGRESS; LOCI;
D O I
10.1038/s42003-024-06742-0
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Genetic risk modeling for dementia offers significant benefits, but studies based on real-world data, particularly for underrepresented populations, are limited. We employ an Elastic Net model for dementia risk prediction using single-nucleotide polymorphisms prioritized by functional genomic data from multiple neurodegenerative disease genome-wide association studies. We compare this model with APOE and polygenic risk score models across genetic ancestry groups (Hispanic Latino American sample: 610 patients with 126 cases; African American sample: 440 patients with 84 cases; East Asian American sample: 673 patients with 75 cases), using electronic health records from UCLA Health for discovery and the All of Us cohort for validation. Our model significantly outperforms other models across multiple ancestries, improving the area-under-precision-recall curve by 31-84% (Wilcoxon signed-rank test p-value <0.05) and the area-under-the-receiver-operating characteristic by 11-17% (DeLong test p-value <0.05) compared to the APOE and the polygenic risk score models. We identify shared and ancestry-specific risk genes and biological pathways, reinforcing and adding to existing knowledge. Our study highlights the benefits of integrating functional mapping, multiple neurodegenerative diseases, and machine learning for genetic risk models in diverse populations. Our findings hold potential for refining precision medicine strategies in dementia diagnosis.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Dose-Response Modeling: Extrapolating From Experimental Data to Real-World Populations
    Pratt, Adrian
    Bennett, Emma
    Gillard, Joseph
    Leach, Steve
    Hall, Ian
    RISK ANALYSIS, 2021, 41 (01) : 67 - 78
  • [2] Real-World Data Modeling
    Kotanchek, Mark
    PROCEEDINGS OF THE FOURTEENTH INTERNATIONAL CONFERENCE ON GENETIC AND EVOLUTIONARY COMPUTATION COMPANION (GECCO'12), 2012, : 1349 - 1378
  • [3] REAL-WORLD DATA MODELING
    Kotanchek, Mark
    GECCO-2010 COMPANION PUBLICATION: PROCEEDINGS OF THE 12TH ANNUAL GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, 2010, : 2863 - 2895
  • [4] From Trial to Target Populations - Calibrating Real-World Data
    Najafzadeh, Mehdi
    Schneeweiss, Sebastian
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (13): : 1203 - 1205
  • [5] Real-world study: from real-world data to real-world evidence
    Wen, Yi
    TRANSLATIONAL BREAST CANCER RESEARCH, 2020, 1
  • [6] Deriving Real-World Insights From Real-World Data
    Baker, Stuart G.
    ANNALS OF INTERNAL MEDICINE, 2019, 170 (09) : 664 - 665
  • [7] Dementia risk analysis using temporal event modeling on a large real-world dataset
    R. Andrew Taylor
    Aidan Gilson
    Ling Chi
    Adrian D. Haimovich
    Anna Crawford
    Cynthia Brandt
    Phillip Magidson
    James M. Lai
    Scott Levin
    Adam P. Mecca
    Ula Hwang
    Scientific Reports, 13
  • [8] Dementia risk analysis using temporal event modeling on a large real-world dataset
    Taylor, R. Andrew
    Gilson, Aidan
    Chi, Ling
    Haimovich, Adrian D.
    Crawford, Anna
    Brandt, Cynthia
    Magidson, Phillip
    Lai, James M.
    Levin, Scott
    Mecca, Adam P.
    Hwang, Ula
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [9] MODELING DYNAMIC-SYSTEMS FROM REAL-WORLD DATA
    MEES, A
    MEASURES OF COMPLEXITY AND CHAOS, 1989, 208 : 345 - 348
  • [10] Association evaluations of oral anticoagulants with dementia risk based on genomic and real-world data
    Ma, Junlong
    Chen, Heng
    Zou, Chan
    Yang, Guoping
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2024, 130